EGFR and non-small cell lung carcinoma: DRAM1 promoted activated EGFR degradation in PC9 cells and in EGF-stimulated A549 cells, limiting EGFR recycling to the cell surface, resulting in downregulated EGFR levels in EGFR-mutant NSCLC cells and in EGF-stimulated A549 cells.